These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 1701837)
1. Effect of ferric ion and active oxygen scavenger on monoamine release in the striatum of the rat. Yokoi I; Kabuto H; Yamamoto M; Mori A Jpn J Psychiatry Neurol; 1990 Jun; 44(2):440-1. PubMed ID: 1701837 [No Abstract] [Full Text] [Related]
2. Effects of carbamazepine and ipsapirone on turnovers of monoamines in the rat brain. Nibuya M; Kanba S; Kinoshita N; Suzuki E; Yagi G; Nakaki T; Kato R Jpn J Psychiatry Neurol; 1991 Mar; 45(1):127-8. PubMed ID: 1721659 [No Abstract] [Full Text] [Related]
3. Dynamic characteristics of dopamine, norepinephrine and serotonin metabolism in axonal endings of the rat hypothalamus and striatum during hypoxia: a study using HPLC with electrochemical detection. Saligaut C; Chretien P; Daoust M; Moore N; Boismare F Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):343-9. PubMed ID: 2426539 [TBL] [Abstract][Full Text] [Related]
4. EPC-K1, a hydroxyl radical scavenger, prevents 6-hydroxydopamine-induced dopamine depletion in the mouse striatum by up-regulation of catalase activity. Kabuto H; Yokoi I; Iwata-Ichikawa E; Ogawa N Neurochem Res; 1999 Dec; 24(12):1543-8. PubMed ID: 10591404 [TBL] [Abstract][Full Text] [Related]
5. Enhancement by ipsapirone of dopamine release in the rat striatum. GoĊembiowska K; Wedzony K Pol J Pharmacol; 1993; 45(3):299-308. PubMed ID: 7693136 [TBL] [Abstract][Full Text] [Related]
6. Monoamine metabolism in the striatum of the rat brain during drug infusion into the nucleus accumbens. Saul'skaya NB Neurosci Behav Physiol; 1997; 27(6):728-33. PubMed ID: 9406229 [TBL] [Abstract][Full Text] [Related]
7. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain. Gagnaire F; Chalansonnet M; Carabin N; Micillino JC Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643 [TBL] [Abstract][Full Text] [Related]
8. Effects of MPP+ on the release of serotonin and 5-hydroxyindoleacetic acid from rat striatum in vivo. Miyake H; Chiueh CC Eur J Pharmacol; 1989 Jul; 166(1):49-55. PubMed ID: 2478372 [TBL] [Abstract][Full Text] [Related]
9. In vivo electrochemical measurements and electrophysiological studies of rat striatum following neonatal 6-hydroxydopamine treatment. Luthman J; Friedemann M; Bickford P; Olson L; Hoffer BJ; Gerhardt GA Neuroscience; 1993 Feb; 52(3):677-87. PubMed ID: 7680793 [TBL] [Abstract][Full Text] [Related]
10. [Biochemical changes in 24-month-old Wistar rats]. Roman F; Della Zuana O; Lonchampt M; Saint Romas G; Duhault J C R Seances Soc Biol Fil; 1984; 178(4):372-81. PubMed ID: 6084545 [TBL] [Abstract][Full Text] [Related]
11. Effect of U and 137Cs chronic contamination on dopamine and serotonin metabolism in the central nervous system of the rat. Houpert P; Lestaevel P; Amourette C; Dhieux B; Bussy C; Paquet F Can J Physiol Pharmacol; 2004 Feb; 82(2):161-6. PubMed ID: 15052298 [TBL] [Abstract][Full Text] [Related]
12. Effects of tamoxifen on striatal dopamine and 5-hydroxytryptamine release in freely moving male rats: an in-vivo microdialysis investigation. Chaurasia CS; Chen CE; Rubin J; Dewey SL J Pharm Pharmacol; 1998 Dec; 50(12):1377-85. PubMed ID: 10052853 [TBL] [Abstract][Full Text] [Related]
13. Changes in rat brain monoamine turnover following chronic antidepressant administration. Sugrue MF Life Sci; 1980 Feb; 26(6):423-9. PubMed ID: 6154860 [No Abstract] [Full Text] [Related]
14. MK-801 protects against amphetamine-induced striatal dopamine depletion in iprindole-treated rats, but not against brain serotonin depletion after p-chloroamphetamine administration. Henderson MG; Hemrick-Luecke S; Fuller RW Ann N Y Acad Sci; 1992 May; 648():286-8. PubMed ID: 1379012 [No Abstract] [Full Text] [Related]
15. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Perry KW; Fuller RW Life Sci; 1992; 50(22):1683-90. PubMed ID: 1375306 [TBL] [Abstract][Full Text] [Related]
16. The effect of neuropeptide Y on striatal catecholamines. Beal MF; Frank RC; Ellison DW; Martin JB Neurosci Lett; 1986 Oct; 71(1):118-23. PubMed ID: 2431356 [TBL] [Abstract][Full Text] [Related]
17. Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence. Cadet JL; Katz M; Jackson-Lewis V; Fahn S Brain Res; 1989 Jan; 476(1):10-5. PubMed ID: 2492442 [TBL] [Abstract][Full Text] [Related]
18. Reduced haloperidol: effects on striatal dopamine metabolism and conversion to haloperidol in the rat. Korpi ER; Wyatt RJ Psychopharmacology (Berl); 1984; 83(1):34-7. PubMed ID: 6204352 [TBL] [Abstract][Full Text] [Related]
19. Melatonin reverses neurochemical alterations induced by 6-OHDA in rat striatum. Aguiar LM; Vasconcelos SM; Sousa FC; Viana GS Life Sci; 2002 Jan; 70(9):1041-51. PubMed ID: 11862988 [TBL] [Abstract][Full Text] [Related]
20. Lack of mitigation of methamphetamine-induced neurotoxicity by ganglioside GM1 or vitamin E. Ali SF Ann N Y Acad Sci; 1995 Sep; 765():311. PubMed ID: 7486624 [No Abstract] [Full Text] [Related] [Next] [New Search]